Michael S. Cuffe Sells 2,400 Shares of HCA Healthcare Inc (HCA) Stock
HCA Healthcare Inc (NYSE:HCA) insider Michael S. Cuffe sold 2,400 shares of the firm’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $86.63, for a total value of $207,912.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
HCA Healthcare Inc (NYSE HCA) traded down $2.38 on Thursday, reaching $86.45. The company’s stock had a trading volume of 3,414,900 shares, compared to its average volume of 2,309,322. The firm has a market cap of $31,450.49, a price-to-earnings ratio of 13.48, a P/E/G ratio of 1.30 and a beta of 0.56. The company has a debt-to-equity ratio of -6.46, a current ratio of 1.68 and a quick ratio of 1.41. HCA Healthcare Inc has a 12-month low of $71.18 and a 12-month high of $91.03.
HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, October 31st. The company reported $1.21 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $1.21. The firm had revenue of $10.70 billion for the quarter, compared to analyst estimates of $10.70 billion. HCA Healthcare had a negative return on equity of 47.16% and a net margin of 6.13%. The company’s revenue was up 4.1% on a year-over-year basis. During the same quarter last year, the firm posted $1.45 EPS. equities research analysts expect that HCA Healthcare Inc will post 6.56 EPS for the current year.
A number of research analysts have recently commented on the company. Robert W. Baird reissued a “buy” rating on shares of HCA Healthcare in a report on Thursday, September 28th. Credit Suisse Group assumed coverage on HCA Healthcare in a report on Thursday, November 2nd. They set an “outperform” rating and a $95.00 price objective on the stock. Piper Jaffray Companies reissued a “buy” rating and set a $92.00 price objective on shares of HCA Healthcare in a report on Wednesday, October 4th. Cantor Fitzgerald reissued a “buy” rating and set a $95.00 price objective on shares of HCA Healthcare in a report on Friday, October 13th. Finally, Raymond James Financial lowered HCA Healthcare from a “strong-buy” rating to a “market perform” rating in a report on Wednesday, October 18th. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and nineteen have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $90.20.
WARNING: This article was originally posted by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark laws. The correct version of this article can be viewed at https://www.watchlistnews.com/michael-s-cuffe-sells-2400-shares-of-hca-healthcare-inc-hca-stock/1776251.html.
HCA Healthcare Company Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.